PD19: Infections/Inflammation/Cystic Disease of the Genitourinary Tract: Kidney & Bladder II

Podium Session Moderator(s)

• 

  Kait Al, Dr.

  Western University
• 

  J. Purves, MD, PhD

  Duke University Medical Center
• 

  Kymora Scotland, Dr.

  Assistant Professor
  University of California Los Angeles

Presentations:

• 1:00 PM – 1:10 PM CST

  PD19-01: C3a/C3aR1 Signaling as a Crucial Pathogenic Mechanism in Membranous Nephropathy
  

  Podium Presenter: Astgik Petrosyan, PHD
• 1:10 PM – 1:20 PM CST

  PD19-02: Involvement of Hippo/TAZ Pathway in Metabolic Alterations during Renal Fibrosis
  

  Podium Presenter: Derek Friedman, MD, BS
• 1:20 PM – 1:30 PM CST

  PD19-03: The Delivery of the Recombinant Protein Cocktail Identified by Stem Cell-Derived Secretome Analysis Accelerates Kidney Repair After Renal Ischemia-Reperfusion Injury
  

  Podium Presenter: John D. Jackson, PHD
• 1:30 PM – 1:40 PM CST

  PD19-04: A Novel, High-Throughput Urosepsis Mouse Model
  

  Podium Presenter: Dirk Lange, PHD – The Stone Centre At Vancouver General Hospital
• 1:40 PM – 1:50 PM CST

  PD19-05: Elevated prothrombin fragment 1+2 is a risk factor of severe acute kidney injury in patients with urological sepsis
  

  Podium Presenter: Naoki Fujita, MD
• 1:50 PM – 2:00 PM CST

  PD19-06: Impact of acute kidney injury on future cardiovascular disease events and renal impairment in patients with urological sepsis
  

  Podium Presenter: Naoki Fujita, MD
• 2:00 PM – 2:10 PM CST

  PD19-07: A S. haematobium Immunomodulatory Protein Prevents Intraabdominal Sepsis
  

  Podium Presenter: Michael Hsieh, MD, PHD – West Wing Urology
• 2:10 PM – 2:20 PM CST

  PD19-08: The urinary fungal microbiome in those with overactive bladder is less abundant in Malassezia and more abundant in Aspergillus relative to healthy controls
  

  Podium Presenter: Glenn T. Werneburg, MD,PhD
• 2:20 PM – 2:30 PM CST

  PD19-09: Immunoprophylaxis with autovaccine decreases hospital admissions and emergency room visits in patients with neurogenic bladder
  

  Podium Presenter: Miguel Bonillo Garcia, MD
• 2:30 PM – 2:40 PM CST

  PD19-10: Progression of overactive bladder symptoms in patients with prior SARS-CoV-2 infection
  

  Podium Presenter: Priya Padmanabhan, MD (she/her/hers)
• 2:40 PM – 2:50 PM CST

  PD19-11: Diabetes causes temporal changes in cholinergic-mediated bladder contractility due to inflammation via the NLRP3 inflammasome in female Akita mice
  

  Podium Presenter: Michael Odom, PHD
• 2:50 PM – 3:00 PM CST

  PD19-12: Patient Reported Outcome Measures following Hyperbaric Oxygen Therapy for Radiation Cystitis
  

  Podium Presenter: Alexandra Hunter